Molecure S.A.

WSE:MOC 株式レポート

時価総額：zł210.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Molecure マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Marcin Szumowski

最高経営責任者

zł473.2k

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権0.7%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間2.8yrs

経営陣の近況

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO（最高経営責任者

Marcin Szumowski

no data

在職期間

zł473,205

報酬

Dr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Marcin Szumowski
Co-Founderno datazł473.21k0.70%
PLN 1.5m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł421.09k0.20%
PLN 430.6k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.8yrszł473.21k0.11%
PLN 235.7k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.8yrszł348.41k0.034%
PLN 72.4k
Samson Fung
Chief Medical Officer & Member of Management Board1.8yrszł999.47kデータなし
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.8yrszł500.00k3.01%
PLN 6.3m
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno dataデータなしデータなし
Magdalena Tyszkiewicz
Head of CMC4.8yrsデータなしデータなし
Marta Borkowska
Director of the Management Board Office2.8yrsデータなしデータなし

3.8yrs

平均在職期間

経験豊富な経営陣: MOCの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Luke O'Neill
Member of Scientific Advisory Boardno dataデータなしデータなし
Reynold A. Panettieri
Member of Scientific Advisory Boardno dataデータなしデータなし
Bart Lambrecht
Member of Scientific Advisory Boardno dataデータなしデータなし
Tomasz Piec
Vice Chairman of the Supervisory Board4.8yrszł133.62kデータなし
Douglas Hay
Member of Scientific Advisory Boardno dataデータなしデータなし
Paul Van Der Horst
Independent Chairman of the Supervisory Board2.8yrszł132.99k0.059%
PLN 124.8k
Nancy Van Osselaer
Independent Member of the Supervisory Board2.8yrszł124.22kデータなし
Agnieszka Motyl
Member of the Supervisory Board1.3yrszł44.45kデータなし
Pawel Trawkowski
Independent Member of the Supervisory Board2.3yrszł124.22kデータなし

2.8yrs

平均在職期間

経験豊富なボード: MOCの 取締役会 は 経験豊富 ではない ( 2.7年の平均在任期間) ため、新しい取締役会が必要であると考えられます。